Hydra Biosciences Company

Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Technology: Cancer
Industry: PharmTech
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2001
Employees Number: 11-50
Funding Status: Late Stage Venture
Total Funding: 94877500
Estimated Revenue: $1M to $10M
Last Funding Type: Series E

Visit Website
Register and Claim Ownership